Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06954181Completed
Randomised, open-label trial of diclofenac in pain (3 arms), sponsored by Haleon. Primary endpoints: Concentration of Voltaren Schmerzgel Forte; 2.32% (Diclofenac) in Water at Day 5 and Amount of Test Product Residues by Gravimetrical Measurements at Day 5. Started Mar 2025; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06954181.